Left Ventricular Dysfunction clinical trials at UCLA

2 in progress, 1 open to eligible people

Showing trials for

  • Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

    open to eligible people ages up to 17 years

    This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline to Week 16. The primary hypothesis is Vericiguat is superior to placebo in reducing NT-proBNP at Week 16.

    Los Angeles, California and other locations

  • BioVentrix Revivent TC™ System Clinical Study

    Sorry, in progress, not accepting new patients

    A prospective, multi-center, dual-arm pivotal study of the BioVentrix Revivent TC System, with 2:1 study vs. active concurrent control group allocation ratio. This study will include 126 patients of which 84 patients will be treated with the investigational device and 42 patients will be included in an active control group.

    Los Angeles, California and other locations

Our lead scientists for Left Ventricular Dysfunction research studies include .

Last updated: